With a market capitalization (market cap) of $1.04B — a measure of how much the company is worth — Savara Inc. ranks #2,383 among the 2,418 companies tracked, and 346th in Healthcare as of November 18, 2026. Shares trade at $4.73, up 5.58% on the day.
As of November 18, 2026 · Prices may be delayed
of 2,418 tracked
Market-cap change uses historical capitalization records. Share-price returns are a different series and can differ when the share count changes. Returns below show the total change over each period. Use the CAGR calculator to calculate an annualized return. CAGR calculator. Market cap vs. stock price.
Year-end values and the chart both come from historical market-cap records, not from applying today's share count to past prices. Latest historical observation November 18, 2026. The headline market cap is from the ranking update on November 18, 2026.
| Year | As of | Market cap | Annual change | Share-price close |
|---|---|---|---|---|
| 2026Latest available | Nov 18, 2026 | $1.2B | -21.52% | $4.71 |
| 2025 | Dec 31, 2025 | $1.53B | +130.16% | $6.03 |
| 2024 | Dec 31, 2024 | $663.57M | -21.50% | $3.07 |
| 2023 | Dec 29, 2023 | $845.26M | +256.95% | $4.70 |
Ranking figure $1.04B as of November 18, 2026.
Market cap = share price × shares outstanding.
Savara Inc.'s ranking market cap is the reported market cap from the latest ranking update, with a share price of $4.69 as of November 18, 2026. Charts and the year-end table use a separate historical market-cap series, last observed at $1.2B on November 18, 2026. See how the ranking works.
The ranking snapshot ($1.04B as of November 18, 2026) is FMP company-screener market cap. The historical observation ($1.2B on November 18, 2026) is FMP historical-market-capitalization for the same ticker. Showing the same calendar date does not make them the same observation: ranking as-of is a snapshot timestamp displayed as a date, and the historical series is a date-stamped point. The live quote market cap agrees with the ranking snapshot. This page does not replace one series with the other.
Current shares outstanding are unavailable from the latest quote. Shares outstanding vs. float.
The latest annual report (FY 2025) used a weighted-average 222,387,531 shares. That figure is an average for the year, not the live count in the market-cap formula.
Book equity: assets minus liabilities on the latest annual report.
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
Undefined when revenue is zero
Undefined when revenue is zero
FY 2025
FY 2025
Undefined when revenue is zero
FY 2025
Undefined when revenue is zero
FY 2025
FY 2025
FY 2025
Quote as of . Prices may be delayed. Day figures refer to the quote's trading session.
Latest quote: $4.69. The headline price of $4.73 is from the ranking update on Nov 18, 2026. These updates can differ in timing.
Largest U.S.-listed companies in the same sector. These companies may serve different markets.
| Rank | Company | Market cap | 1D |
|---|---|---|---|
| #11 | Eli Lilly and Company LLY | $1.31T | -1.68% |
| #19 | Johnson & Johnson JNJ | $664.04B | -1.00% |
| #23 |
Savara Inc. is a biopharmaceutical firm in the clinical development phase, specializing in therapies for uncommon respiratory conditions. Their primary investigational drug, molgramostim, is an inhaled form of granulocyte-macrophage colony-stimulating factor (GM-CSF). This compound is currently undergoing Phase III trials to address autoimmune pulmonary alveolar proteinosis.
Summary from the company profile (Financial Modeling Prep). Principal financial figures above are for FY 2025.
Visit websiteAs of November 18, 2026, Savara Inc. (SVRA) is worth $1.04B — that is its market capitalization, the total value of its outstanding shares on MarketCapLens.
A company’s net worth is its shareholders’ equity: assets minus liabilities on the balance sheet. That is book equity, not market cap. For FY 2025, Savara Inc.’s book equity is about $203.13M. Market cap is the market value of the outstanding shares. As of November 18, 2026, its market cap is $1.04B. Book equity is an accounting remainder; market cap is a trading value. Neither is a person’s net worth.
Savara Inc. ranks #2,383 among the 2,418 companies tracked on MarketCapLens. In Healthcare it ranks #346 of 353.
Financial figures are annual and labeled with their fiscal year (FY). Current-price P/E uses the latest available share price and annual earnings per share.
Over the past year, market cap and share price moved by different amounts. Share count can change independently of price. What changes market cap.
| 2022 | Dec 30, 2022 | $236.8M | +25.00% | $1.55 |
|---|
| 2021 | Dec 31, 2021 | $189.43M | — | $1.24 |
|---|
Last observation of each calendar year from historical market-cap records. The current year is through the latest date, not a completed year-end. Share-price close is the matching session for context — we do not rebuild cap from today's share count.
Undefined when revenue is zero
Return on equity data unavailable for FY 2025
FY 2025
Return on assets data unavailable for FY 2025
FY 2025
| $508.92B |
| -1.58% |
| #31 | Merck & Co., Inc. MRK | $342.3B | -3.09% |
| #35 | UnitedHealth Group Incorporated UNH | $318.26B | -8.69% |
| #38 | Novartis AG NVS | $294.55B | -1.99% |
Companies immediately above and below in the overall ranking. They may be in a different sector.
| Rank | Company | Market cap | 1D |
|---|---|---|---|
| #2380 | SI-BONE, Inc. SIBN | $1.04B | -0.05% |
| #2381 | Dauch Corp. DCH | $1.04B | +1.50% |
| #2382 | XPEL, Inc. XPEL | $1.04B | +2.72% |
| #2384 | Castle Biosciences, Inc. CSTL | $1.04B | +2.50% |
| #2385 | Akso Health Group AHG | $1.04B | -1.61% |
| #2386 | Myers Industries, Inc. MYE | $1.04B | +3.67% |
Savara Inc.’s ranking market cap of $1.04B comes from the same snapshot as the rest of this site, as of November 18, 2026. It is not share price multiplied by the FY 2025 weighted-average share count of 222,387,531. The ranking snapshot ($1.04B as of November 18, 2026) is FMP company-screener market cap. The historical observation ($1.2B on November 18, 2026) is FMP historical-market-capitalization for the same ticker. Showing the same calendar date does not make them the same observation: ranking as-of is a snapshot timestamp displayed as a date, and the historical series is a date-stamped point. The live quote market cap agrees with the ranking snapshot. This page does not replace one series with the other.
Over the past year, Savara Inc.’s market cap is up 29.25%, using historical market-cap records rather than today’s share count applied to past prices.
Savara Inc. (SVRA) shares trade at $4.73, up 5.58% on the day, as of November 18, 2026.
Live P/E is share price divided by annual earnings per share. Sales-based ratios such as price/sales and operating margin are also blank when revenue is zero — not a 0× multiple.